Ying Zheng

机构：Guangzhou University of Chinese Medicine, Sir Run Run Shaw Hospital, Zhejiang University, Guangzhou Medical University · ORCID：0009-0008-4072-1773

发表论文 95 篇 · 总被引 3343 次 · h-index 32

代表论文

• Neoadjuvant Durvalumab Alone or Combined with Novel Immuno-Oncology Agents in Resectable Lung Cancer: The Phase II NeoCOAST Platform Trial (2023 · Cancer Discovery · 被引 124)
• CircRNA: A new class of targets for gastric cancer drug resistance therapy (2023 · Pathology & Oncology Research · 被引 25)
• Visual–language foundation models in medicine (2024 · The Visual Computer · 被引 14)
• Zinc finger protein ZNF638 regulates triglyceride metabolism via ANGPTL8 in an estrogen dependent manner (2024 · Metabolism · 被引 7)
• Abstract 2961: AZD9592, an EGFR/cMET bispecific antibody-drug conjugate (ADC), demonstrates target-dependent efficacy in colorectal cancer (CRC) patient-derived xenograft (PDX) models (2025 · Cancer Research · 被引 3)
• 401P Utidelone in combination with etoposide and bevacizumab in HER2-negative breast cancer with brain metastasis (UTOBIA-BM): A prospective, single-arm, phase II trial (2023 · Annals of Oncology · 被引 3)